- Q2 2023 Biovica International AB Earnings Call TranscriptDec 15, 2022€0.742 (+1.50%)Earnings
- Biovica International AB Market update FDA clearance TranscriptAug 18, 2022
- Q4 2022 Biovica International AB Earnings Call TranscriptJun 16, 2022€3.15 (+2.75%)Earnings
- Biovica International AB Corporate Analyst Meeting TranscriptMay 17, 2022
- Q3 2022 Biovica International AB Earnings Call TranscriptMar 15, 2022€2.62 (+7.74%)Earnings
- Q2 2022 Biovica International AB Earnings Call TranscriptDec 01, 2021€3.68 (+0.95%)Earnings
- Q1 2022 Biovica International AB Earnings Call TranscriptSep 02, 2021€5.85 (+6.29%)Earnings
- Biovica International AB CEO's Presentation Annual General Meeting 2021 - Pre-Recorded TranscriptAug 27, 2021
- Q4 2021 Biovica International AB Earnings Call TranscriptJun 18, 2021€4.48 (-0.22%)Earnings
- Biovica International AB Capital Markets Day (Virtual) TranscriptJun 09, 2021
- Q3 2021 Biovica International AB Earnings Call TranscriptMar 18, 2021€4.05 (+7.63%)Earnings
- Q2 2021 Biovica International AB Earnings Call TranscriptDec 08, 2020Earnings
Biovica International AB Capital Markets Day (Virtual) Transcript
()-&
Hello, everyone, and welcome to the Biovica Capital Market Day of 2021. My name is Anders Rylander. I am the CEO of Biovica, and just a few words about my background, which is within management consultant, many years with Accenture and entrepreneurship where I co-founded management consulting company, Axholmen, which led to that I eventually came into contact with Biovica as an investor. And I was attracted by the great potential, both human and commercial, and the fact that we, with our product, can be beneficial for cancer patients on treatment and also for payers and health care providers. We'll get more into detail into that today. So now today, I'm both the CEO and the main shareholder of the company.
And talking about the agenda. And for today, we have 2.5 hours. We'll go through, first of all, a company overview, which I will do, then Dr. Malorni from Prato Hospital will take us through the oncologist perspective as he has a great experience from working with the testing
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)